| Katherine Leslie Baquerizo Nole, MD | |
|
3130 Highland Ave, U Cincinnati Medical Center. Department Of Dermatology, Cincinnati, OH 45219-2399 | |
| (513) 584-4644 | |
| (513) 584-1559 |
| Full Name | Katherine Leslie Baquerizo Nole |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 21 Years |
| Location | 3130 Highland Ave, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124413133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 35136377 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Cincinnati Medical Center, Llc | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Cincinnati Physicians Company Llc | 2264344480 | 1339 |
| University Of Cincinnati Physicians Company Llc | 2264344480 | 1339 |
News Archive
Quidel Corporation, a leading provider of rapid point-of-care diagnostic tests, announced today the signing of a definitive agreement to acquire privately held Diagnostic Hybrids, Inc. for approximately $130 million in cash.
Laboratory Corporation of America® Holdings today announced results for the quarter and year ended December 31, 2010. These results include the operations of Genzyme Genetics for the month of December.
Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.
Measuring a child's kidney function has traditionally been time-consuming, costly, and difficult to perform, but a new equation that uses parameters collected at routine office visits can effectively accomplish this, according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology ( JASN ).
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in the EU, today announced that its partner Auxilium Pharmaceuticals, Inc. has dosed the first patient in its Phase 2b study of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome (adhesive capsulitis).
› Verified 5 days ago
| Entity Name | University Of Cincinnati Physicians Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801840434 PECOS PAC ID: 2264344480 Enrollment ID: O20031105000123 |
News Archive
Quidel Corporation, a leading provider of rapid point-of-care diagnostic tests, announced today the signing of a definitive agreement to acquire privately held Diagnostic Hybrids, Inc. for approximately $130 million in cash.
Laboratory Corporation of America® Holdings today announced results for the quarter and year ended December 31, 2010. These results include the operations of Genzyme Genetics for the month of December.
Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.
Measuring a child's kidney function has traditionally been time-consuming, costly, and difficult to perform, but a new equation that uses parameters collected at routine office visits can effectively accomplish this, according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology ( JASN ).
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in the EU, today announced that its partner Auxilium Pharmaceuticals, Inc. has dosed the first patient in its Phase 2b study of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome (adhesive capsulitis).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Leslie Baquerizo Nole, MD 3130 Highland Ave, U Cincinnati Medical Center. Department Of Dermatology, Cincinnati, OH 45219-2399 Ph: (513) 584-4644 | Katherine Leslie Baquerizo Nole, MD 3130 Highland Ave, U Cincinnati Medical Center. Department Of Dermatology, Cincinnati, OH 45219-2399 Ph: (513) 584-4644 |
News Archive
Quidel Corporation, a leading provider of rapid point-of-care diagnostic tests, announced today the signing of a definitive agreement to acquire privately held Diagnostic Hybrids, Inc. for approximately $130 million in cash.
Laboratory Corporation of America® Holdings today announced results for the quarter and year ended December 31, 2010. These results include the operations of Genzyme Genetics for the month of December.
Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.
Measuring a child's kidney function has traditionally been time-consuming, costly, and difficult to perform, but a new equation that uses parameters collected at routine office visits can effectively accomplish this, according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology ( JASN ).
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in the EU, today announced that its partner Auxilium Pharmaceuticals, Inc. has dosed the first patient in its Phase 2b study of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome (adhesive capsulitis).
› Verified 5 days ago
Bria Deshea Barjuca, APRN-CNP Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4450 Eastgate Blvd Ste 232, Cincinnati, OH 45245 Phone: 513-770-4212 | |
Lauren Grau, APRN Dermatology Medicare: Not Enrolled in Medicare Practice Location: 331 W 4th St, Cincinnati, OH 45202 Phone: 614-500-7000 | |
Kalyani Shriram Marathe, MD, MPH Dermatology Medicare: Medicare Enrolled Practice Location: 3333 Burnet Ave, Ml 3004, Cincinnati, OH 45229 Phone: 513-636-4215 Fax: 513-636-5867 | |
Debra L Breneman, M. D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3130 Highland Ave, Cincinnati, OH 45219 Phone: 513-584-3686 Fax: 513-475-7636 | |
Brett M Coldiron, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3024 Burnet Ave, Cincinnati, OH 45219 Phone: 513-221-2828 Fax: 513-872-5721 | |
Dr. Richard S Moraites, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 7717 Montgomery Road, Cincinnati, OH 45236 Phone: 513-793-4021 Fax: 513-793-4078 |